A rare case of Miller Fisher variant of Guillain-Barré Syndrome (GBS) induced by a checkpoint inhibitor

With the recent development of novel, more potent cancer treatment, in particular, immune ‘checkpoint inhibitors’, cases of neurological immune-related adverse events are on the rise. Although rare, this includes Guillain-Barré Syndrome (GBS). We present the case of a 68-year-old male who was admitt...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:BMJ Case Rep
Main Authors: McNeill, Caitlin Jane, Fehmi, Janev, Gladwin, James, Price, Christopher
פורמט: Artigo
שפה:Inglês
יצא לאור: BMJ Publishing Group 2019
נושאים:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700679/
https://ncbi.nlm.nih.gov/pubmed/31413049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229443
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים